Advertisement
William Iacona, Somanetics' chief financial officer, will make a 30-minutepresentation on Tuesday, October 7, 2008 at 11:00 a.m. ET. The presentationwill be webcast live. The webcast may be accessed by visiting the InvestorCenter section of Somanetics' website at www.somanetics.com. The presentationalso will be archived on Somanetics' website for 30 days following theconference.
Advertisement
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and marketsthe INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoringsystem that continuously measures changes in the blood oxygen levels in thebrain and elsewhere in the body in patients with or at risk for restrictedblood flow. Surgeons, anesthesiologists and other medical professionals canuse the information provided by the INVOS System, in conjunction with otheravailable information, to identify oxygen imbalances in tissues beneath thesensor and take necessary corrective action, potentially improving patientoutcomes and reducing the costs of care. The INVOS System has a nearly11-year market track record supported by more than 500 clinical references,and is used at nearly 700 U.S. hospitals. Somanetics supports its customersthrough a direct U.S. sales force and clinical education team. Covidienmarkets INVOS System products in Europe, Canada, the Middle East and SouthAfrica and Edwards Lifesciences represents INVOS System products in Japan.For more information visit www.somanetics.com.
SOURCE Somanetics Corporation
